Measure 109

The Oregon Psychiatric Physician’s Association is disappointed that Measure 109, The Psilocybin Mushroom Services Program, has passed in the state of Oregon. We remain concerned that psilocybin is not FDA approved, clinical trials are still ongoing, and psilocybin administration would not require medical oversight for the treatment of Oregonians with mental health conditions. Now that this measure has passed, we look forward to the opportunity to work with the Oregon legislature, the Oregon Health Authority and the Psilocybin Advisory Board to make the use of psilocybin as safe as possible for Oregon residents suffering from mental health conditions. As an organization of Oregon psychiatrists working together to ensure humane care and effective treatment for all persons with mental illness, we will continue our vision to advocate for evidence based, safe and accessible quality psychiatric care for Oregonians. 

Statements

OPPA Position Statement on Measure 109 

American Psychiatric Association Position Statement on Measure 109

Oregon Council of Child and Adolescent Psychiatry Position Statement on Measurement 109

American Academy of Child and Adolescent Psychiatrists statement on Oregon Measure 109

​Oregon Medical Association Statement on Measure 109

Media  

The Oregonian - Editorial Board opposes measure 109

KOIN: Measure 109 - Why several medical organizations oppose legalizing psilocybin therapy

KATU - Your Voice Your Vote     

Further Information

Annotated Measure 109 Text

Article summarizing the limited clinical trials of Psilocybin from the American Journal of Psychiatry (2020) 

Article summarizing clinical trials from the Journal of Psychoactive Drugs (2020)
​


Donate to the OPPA Political Action Committee [Donation Link]